Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term bone-marrow-transplantation. Found 8 abstracts

Baden LR, Bensinger W, Angarone M, Casper C, Dubberke ER, Freifeld AG, Garzon R, Greene JN, Greer JP, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marr KA, Montoya JG, Morris-Engemann A, Pappas PG, Rolston K, Segal B, Seo SK, Swaminathan S, Naganuma M, Shead DA. Prevention and Treatment of Cancer-Related Infections. Journal of the National Comprehensive Cancer Network. 2012 Nov;10(11):1412-45.   PMCID: not NIH funded
Hoppe RT, Advani RH, Ai WY, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Weiss L, Winter JN, Yahalom J, Nccn Clinical Practice Guidelines, Rbone Pp VP, Nellos Gp VP, Nellos Gp VP. NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma. Journal of the National Comprehensive Cancer Network. 2011 Sep;9(9):1020-58.   PMCID: not NIH funded
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O'Connor T, Pirl WF, Rodler E, Rugo HS, Thomas J, Wagner LI. Cancer-Related Fatigue. Journal of the National Comprehensive Cancer Network. 2010 Aug;8(8):904-31.   PMCID: not NIH funded
Gupta V, Tallman MS, He WS, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, Waller EK, DiPersio JF, Bunjes DW, Weisdorf DJ. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 2010 Sep;116(11):1839-48.   PMCID: PMC3173984
Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD, Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM, Hari PN. A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR. Biology of Blood and Marrow Transplantation. 2010 Jan;16(1):35-45.   PMCID: PMC2929576
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, Devetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO, Mughal T, Radich JP, Shah NP, Smith BD, Snyder DS, Talpaz M, Wetzler M. Chronic Myelogenous Leukemia. Journal of the National Comprehensive Cancer Network. 2009 Oct;7(9):984-1023.   PMCID: not NIH funded
Klumpp TR, Herman J, Ulicny J, Emmons RV, Martin ME, Mangan KF. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION. 2006 Nov;38(9):615-20.
Ibrahim D, Smith MR, Varterasian M, Karanes C, Millenson M, Yeslow G, Pemberton P, Lai P, Abrams J, Al-Katib A. Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma. Leukemia & lymphoma. 2004 Oct;45(10):2079-84.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term bone-marrow-transplantation

bone-marrow-transplantation stem-cell transplantation treatment chemotherapy high-dose therapy placebo-controlled trial transplantation NCCN Guidelines versus-host-disease publication bias rituximab 2007 doloff da-v5-ps23 management PEND response evaluation radiation-therapy Hodgkin lymphoma reduced-intensity prognostic factors in-situ hybridization hematopoietic stem cell transplantation dasatinib positron-emission-tomography tyrosine kinase inhibitor lymphoma pneumocystis-carinii-pneumonia herpes-simplex-virus classical Hodgkin disease chronic myelogenous patients receiving chemotherapy imatinib group quality-of-life progressive multifocal elderly-patients stem-cell combined-modality Allogeneic transplantation study-group ghsg 1977 tbals dw-annals of internal medicine-v87-p552 autologous blood Transplantation randomized controlled-trial complete cytogenetic hodgkins-disease survivors non-hodgkins-lymphoma metaanalysis combination chemotherapy disease patients screening fatigue therapy combined donor lymphocyte infusions modality therapy Immunology negative predictive-value bone marrow transplantation relapsed Hodgkin lymphoma 1984 rson sl-annals of internal medicine-v100-p345 involved-field radiotherapy malignant-lymphoma adults lymphocyte predominance hepatitis-b-virus class-i colony-stimulating factor incompatibility chronic myeloid-leukemia regeneration survival fine-needle-aspiration term follow-up 2007 doloff da-v5-ps1 Hematology first relapse risk cognitive-behavioral therapy severe aplastic-anemia high-dose chemotherapy invasive pulmonary aspergillosis nilotinib Hodgkin disease karyotyping imatinib mesylate Unrelated 1994 lcott ja-journal of clinical oncology-v12-p107 hpc transplantation identical siblings 1994 entice hg-lancet-v343-p749 leukemia carcinoma 1988 lcott ja-archives of internal medicine-v148-p2561 graft-versus-host disease leukoencephalopathy acute myelogenous leukemia 1980 vita vt-v92-p587 follow-up l-carnitine supplementation intervention ABO system hematologic response Clinical Practice Guidelines chemotherapy plus Oncology european patients receiving imatinib chronic lymphocytic-leukemia cytogenetic relaxation breathing exercise risk-factors radiation therapy aggressive lymphoma allogenic HSCT 1992 lcott ja-journal of clinical oncology-v10-p316 NCCN Clinical Practice Guidelines salvage therapy clinical-trials polymerase-chain-reaction
Last updated on Wednesday, February 05, 2020